Tecentriq Interactions
There are 622 drugs known to interact with Tecentriq (atezolizumab), along with 13 disease interactions. Of the total drug interactions, 25 are major, and 597 are moderate.
- View all 622 medications that may interact with Tecentriq
- View Tecentriq disease interactions (13)
Most frequently checked interactions
View interaction reports for Tecentriq (atezolizumab) and the medicines listed below.
- Alimta (pemetrexed)
- allopurinol
- amiodarone
- amitriptyline
- amlodipine
- atorvastatin
- Avastin (bevacizumab)
- Baraclude (entecavir)
- Benadryl (diphenhydramine)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- carboplatin
- dexamethasone
- Eliquis (apixaban)
- Enbrel (etanercept)
- Inderal (propranolol)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- magnesium oxide
- melatonin
- metformin
- Metoprolol Succinate ER (metoprolol)
- ondansetron
- oxycodone
- pantoprazole
- prednisone
- Protonix (pantoprazole)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- tamsulosin
- Vitamin D3 (cholecalciferol)
Tecentriq disease interactions
There are 13 disease interactions with Tecentriq (atezolizumab) which include:
- endocrinopathies
- hepatitis
- infections
- meningitis
- neuropathy
- pancreatitis
- colitis
- liver disease
- pneumonitis
- renal impairment
- HSCT
- myasthenia gravis
- organ transplant
Report options
QR code containing a link to this page
More about Tecentriq (atezolizumab)
- Tecentriq consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
